Miquel Sans

Miquel Sans

Auto-generated profile, based on publicly available information

Miquel Sans

Department of Gastroenterology, Hospital Clínic i Provincial/IDIBAPS, 170 Villarroel, 08036 Barcelona, CIBER EHD, Catalunya, Spain

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in World Journal of Gastroenterology
Verified
Journal Article
Open access
TNTiago Nunes
Tiago Nunes
GFGionata Fiorino
Gionata Fiorino
SDSilvio Danese
Silvio Danese
MSMiquel Sans
Miquel Sans
Inflammatory bowel disease (IBD) develops in genetically susceptible individuals due to the influence of environmental factors, leading to an abnormal recognition of microbiota antigens by the innate immune system which triggers an exaggerated immune response and subsequent bowel tissue damage. IBD has been more frequently found in families, an observation that could be due to either genetic, environmental or both types of factors present in these families. In addition to expanding our knowledge on IBD pathogenesis, defining the specific contribution to familial IBD of each one of these factors might have also clinical usefulness. We review the available evidence on familial IBD pathogenesis.

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MEMaría Josefina Etchevers
María Josefina Etchevers
MAMontserrat Aceituno
Montserrat Aceituno
MSMiquel Sans
Miquel Sans
Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease

9 March 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SASandra Angulo
Sandra Angulo
Albert MoralesAlbert Morales
Albert Morales
SDSilvio Danese
Silvio Danese
LLLaura Llacuna
Laura Llacuna
MMMaria Carme Masamunt
Maria Carme Masamunt
MSMiquel Sans
Miquel Sans
Probiotics appear to be beneficial in inflammatory bowel disease, but their mechanism of action is incompletely understood. We investigated whether probiotic-derived sphingomyelinase mediates this beneficial effect. Neutral sphingomyelinase (NSMase) activity was measured in sonicates of the probiotic L. brevis (LB) and S. thermophilus (ST) and the non-probiotic E. coli (EC) and E. faecalis (EF). Lamina propria mononuclear cells (LPMC) were obtained from patients with Crohn's disease (CD) and Ulcerative Colitis (UC), and peripheral blood mononuclear cells (PBMC) from healthy volunteers, analysing LPMC and PBMC apoptosis susceptibility, reactive oxygen species (ROS) generation and JNK activation. In some experiments, sonicates were preincubated with GSH or GW4869, a specific NSMase inhibitor. NSMase activity of LB and ST was 10-fold that of EC and EF sonicates. LB and ST sonicates induced significantly more apoptosis of CD and UC than control LPMC, whereas EC and EF sonicates failed to induce apoptosis. Pre-stimulation with anti-CD3/CD28 induced a significant and time-dependent increase in LB-induced apoptosis of LPMC and PBMC. Exposure to LB sonicates resulted in JNK activation and ROS production by LPMC. NSMase activity of LB sonicates was completely abrogated by GW4869, causing a dose-dependent reduction of LB-induced apoptosis. LB and ST selectively induced immune cell apoptosis, an effect dependent on the degree of cell activation and mediated by bacterial NSMase. These results suggest that induction of immune cell apoptosis is a mechanism of action of some probiotics, and that NSMase-mediated ceramide generation contributes to the therapeutic effects of probiotics.

1 March 2011 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
JLJeroni Luna
Jeroni Luna
MMMaria Carme Masamunt
Maria Carme Masamunt
MRMariana Rickmann
Mariana Rickmann
RMRut Mora
Rut Mora
CECarolina España
Carolina España
MSMiquel Sans
Miquel Sans
Background. Excessive fibroblast expansion and extracellular matrix (ECM) deposition are key events for the development of bowel stenosis in Crohn's dis

1 May 2011 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
JLJeroni Luna
Jeroni Luna
MMMaria Carme Masamunt
Maria Carme Masamunt
ILIan Craig Lawrance
Ian Craig Lawrance
MSMiquel Sans
Miquel Sans
An exquisite equilibrium between cell proliferation and programmed cell death is required to maintain physiological homeostasis. In inflammatory bowel disease, and especially in Crohn's disease, enhanced proliferation along with defective apoptosis of immune cells are considered key elements of pathogenesis. Despite the relatively limited attention that has been given to research efforts devoted to intestinal fibrosis to date, there is evidence suggesting that enhanced proliferation along with defective programmed cell death of mesenchymal cells can significantly contribute to the development of excessive fibrogenesis in many different tissues. Moreover, some therapies have demonstrated potential antifibrogenic efficacy through the regulation of mesenchymal cell proliferation and programmed cell death. Further understanding of the pathways involved in the regulation of mesenchymal cell proliferation and apoptosis is, however, required.

1 May 2011 in Gastroenterology
Verified
Journal Article
Closed access
MSMiquel Sans
Miquel Sans
ARAntonio López-San Román
Antonio López-San Román
MEMaria Esteve
Maria Esteve
FBFernando Bermejo
Fernando Bermejo
VGValle García-Sánchez
Valle García-Sánchez
JPJulian Panes
Julian Panes